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Abstract 
A survey of conditions for the palladium catalyzed intramolecular Heck cyclization of protected amines has 
shown that the Herrmann-Beller palladacycle can be exploited under ‘cationic’ conditions to provide a robust 
and rapid route (<2 h) to the synthesis of single double-bond isomer phenanthridines in excellent yield (76-
99%). In addition, the same cyclization can be performed under ‘neutral’ conditions to provide 
phenanthridines with a double-bond isomer profile suitable for exploitation in diversity-based applications. 
We have also shown that the highly reactive (
t
Bu3P)2Pd catalyst can induce cyclization at low temperatures 
(≤50 °C), giving similar results to the ‘neutral’ conditions, and offering an alternative pathway for sensitive 
substrates. 
 
1. Introduction text 
The phenanthridine framework 1 lies at the heart of a number of natural products including the amaryllidaceae 
alkaloids such as the antiviral lycorine 2;
1,2
 and the papaveraceae benzophenanthridine alkaloids such as the 
tubulin polymerization inhibitor chelidonine 3
3
 and isochelidonine 4 (Figure 1).
4
 These, and the closely related 
class of phenanthridones, are known to exhibit diverse biological activities,
5
 and thus present excellent targets 
for natural product scaffold-based libraries.
6
 Whilst construction of the phenanthridone core, which lies at the 
heart of the antibiotic pancratistatin, has received considerable attention,
5a,b
 the synthesis of phenanthridines is 
comparatively unstudied. 
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Figure 1. Phenanthridine alkaloid natural products. 
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We were attracted to a Heck-cyclization based approach to the phenanthridine framework as there is good 
precedent for cis-stereocontrol in formation of the 6,6-ring junction in related phenanthridone systems.
7
 
However, we were concerned that the conditions reported were potentially limiting in a library-based 
approach to the phenanthridine core due to the lengthy reaction times (typically 24-48 h) and high 
temperatures (typically 110-160 °C) required for the cyclization reaction. Our initial aims were thus two-fold; 
to develop conditions which might overcome these practical problems, whilst at the same time promoting the 
cyclization of a range of functionalized amine precursors to allow access to a diverse library based upon the 
phenanthridine core unit.  
 
2. Results and Discussion 
2.1 Catalyst screening studies 
To find conditions which might be applied to the rapid synthesis of a phenanthridine library using the Heck 
reaction (Scheme 1), we first surveyed a range of standard catalysts. Sulfonamide 5a (P = SO2Me, Table 1) 
was found to be readily accessible through alkylation of commercially available 2-bromobenzylamine with 3-
bromocyclohexene, followed by protection as the methanesulfonamide (84 % yield over 2 steps), and 
provided an excellent substrate for catalyst screening studies (Table 1). 
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Scheme 1. A Heck-cyclization based retrosynthetic analysis of a phenanthridine library. 
 
N
Br
P
5a
N
P
Heck
cyclization
N
P
N
P
N
P
6a 7a 8a 9a
H
H H
H
H
HH
 
Page 3 of 21 
Ent
ry 
Catalyst
a 
Base T 
(°C) 
t (min) Solvent Conversion 
(%)
b 
Ratio 
7a:8a:9a 
1 Pd(OAc)2/PCy3 MeNCy2 (4 eq) 130 70 DMA 99 77:14:9 
2 Pd(OAc)2/PCy3 MeNCy2 (4 eq) 140 60 DMA 99 96:2:2 
3 Pd(OAc)2/PCy3 MeNCy2 (4 eq) 150 30 DMA 98 95:3:2 
4 Pd(OAc)2/PCy3 Et3N (4 eq) 140 70 DMA 58 90:2:8 
5 Pd(OAc)2/PCy3 DIPEA (4 eq) 140 35 DMA 98 92:5:3 
6 Pd(OAc)2/PCy3 K2CO3 (4 eq) 140 40 DMA 87 55:27:18 
7 Pd(OAc)2/PCy3 2,6-lutidine (4 eq) 140 - DMA - - 
8 Pd(OAc)2/PCy3 MeNCy2 (4 eq) 140 35 DMF 95 94:5:1 
9 Herrmann-Beller 
(10) 
MeNCy2 (4 eq) 130 360 DMF 85 39:38:23 
10 Herrmann-Beller 
(10) 
MeNCy2 (4 eq) 140 180 DMF 98 44:31:25 
11 Herrmann-Beller 
(10) 
MeNCy2 (4 eq) 150 110 DMF 88 52:16:32 
12 Herrmann-Beller 
(10) 
AgF (1 eq) 140 180
c 
DMF 76 65:23:12 
13 Herrmann-Beller 
(10) 
Ag3PO4 (1 eq) 140 120 DMF 99 67:18:15 
14 Herrmann-Beller 
(10) 
Ag2CO3 (1 eq) 140 70 DMF 99 85:13:2 
 
Table 1. Catalyst screening for the intramolecular Heck cyclization reaction of sulfonamide 5a (P = SO2Me). 
 
Using Pd(OAc)2/PCy3 under standard conditions (Table 1, entries 1-3) the intramolecular Heck cyclization of 
5a was found to proceed to completion rapidly. In related intramolecular Heck cyclization reactions of 
benzamides, a range of double bond isomers have been reported, including the bridgehead 10b,1 (6a), 1,2 
(7a), and 2,3 (8a) isomers.8,9 In this study, none of the bridgehead double bond isomer was formed, and the 
cis 1,2 isomer (7a) was observed as the major product,10 along with trace amounts of the 2,3 (8a) and 3,4 
(9a) double bond isomers.
11
 Investigation of a range of bases at the optimum reaction temperature (140 °C), 
showed DIPEA gave comparable results to those obtained in the presence of MeNCy2, however Et3N, K2CO3 
and 2,6-lutidine gave lower conversion levels (entries 4-7). We were pleased to observe that a switch in 
solvent from DMA to DMF (entry 8) resulted in similar or even enhanced reactivity with almost total 
conversion in only 35 minutes. However, at the elevated reaction temperatures required to ensure complete 
conversion (140-160 °C), we encountered serious problems with reproducibility, which we ascribed to 
catalyst decomposition and the formation of inert palladium black.
12
 The capricious nature of this catalyst 
system led us to investigate other possible palladium sources. 
The Herrmann-Beller palladacycle (10, Figure 2) is well-known as a highly effective source of Pd(0) for the 
arylation of alkenes.
13
 Its reactivity at elevated temperatures has been attributed to a slow release of Pd(0) into 
the reaction medium, thus maintaining a constant level of the active catalytic species throughout the 
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reaction.
14
 Its use also has precedent in intramolecular cyclization reactions.
15
 The application of 10 as a Pd(0) 
source in conjunction with the optimum base MeNCy2 gave relatively rapid cyclization at a range of 
temperatures (130-150 °C), but led to a diminished selectivity for the 1,2 double bond isomer (entries 9-11). 
With the aim of suppressing double bond migration through a cationic reaction pathway,
16
 we screened the 
use of a range of Ag(I) salts (entries 12-14) as additives.
17
 We were pleased to discover that the use of Ag2CO3 
in conjunction with the Herrmann-Beller catalyst led to rapid conversion (70 mins at 140 °C), good double 
bond isomer ratios, and excellent reproducibility. 
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Figure 2. Herrmann-Beller palladacycle 
 
2.2 Cyclization of a range of functionalized amines 
A range of functionalized amine precursors 5b-e (Boc, Cbz, Bn, PMB) were synthesized from the same 
intermediate as used in formation of sulfonamide 5a in good to excellent yields (81-90%). In all cases our 
optimum conditions employing the Herrmann-Beller catalyst 10 gave excellent conversions to the 
phenanthridine core, strongly favouring the 1,2 isomer (Table 2). With the exception of the PMB-protected 
amine precursor 5e, the reactions were complete in <2 h. The Bn and PMB protected analogues in particular 
showed excellent selectivity for the 1,2 isomer. 
Amine P t (min) Yield (%) Ratio (7:8:9) 
5a SO2Me 70 99 85:13:2 
5b Boc 120 99 83:15:2 
5c Cbz 120 99 92:6:2 
5d Bn 120 92 100:0:0
b
 
5e PMB 160 76 97:3:0 
a
 Reagents and Conditions: aryl halide (1 eq), palladacycle 10 (5 mol %), Ag2CO3 (1 eq), DMF, 140 °C. 
b
 
Minor isomer peaks could not be quantified. 
Table 2. Cyclization reactions of a range of functionalized amines.
a 
 
Page 5 of 21 
The identity and ratios of the Boc and Cbz-protected products (7b-9b and 7c-9c respectively) was determined 
by direct correlation of their 
1
H NMR spectra with their sulfonamide counterparts (7a-9a); and the assignment 
of minor peaks was confirmed by TOCSY experiments. For the Bn and PMB products, extensive 2D NMR 
analysis confirmed that the major product in each of these two cases was the 1,2 isomer (7d and 7e 
respectively), whilst the 2,3 and 3,4 minor products were assigned by analogy with their sulfonamide 
counterparts. 
In order to assess the utility of these conditions on a substrate biased towards the formation of a single double 
bond isomer, we chose to synthesize the gem dimethyl analogue of the phenanthridine ring system, 11. The 
sulfonamide protected cyclization precursor 12 was readily accessed (Scheme 2) through conversion of 
dimedone to the known enone 13;
18,19
 reduction of 13 to the corresponding enol and conversion to allylic 
bromide 14;
20.21
 coupling of bromide 14 with 2-bromobenzylamine; and finally sulfonamide protection of the 
amine (6 steps, 13 % overall yield). Heck cyclization of 12 employing the Herrmann-Beller catalyst resulted 
in quantitative conversion in 2 h to a colourless solid which was shown to be the desired 1,2 3,3-dimethyl-
tetrahydrophenanthridine 11. 
 
O
O 1. CAN, MeOH
rt, 16 h
     
2. i. LiAlH4, Et2O
0 °C - rt, 1 h;
ii. silica, CH2Cl2
3 h
(66% yield
over 2 steps)
13
O
3. LiAlH4, Et2O
0 °C, 40 min
     
4. CBr4, PPh3,
Et2O, rt, 2 h Br
14
(48% yield
over 2 steps)
N
Br
SO2Me
5. o-BrPhCH2NH2•HCl,
DIPEA, MeCN, rt, 16 h
6. MeSO2Cl, Et3N,
CH2Cl2, rt, 3 h
(41% yield
over 2 steps)
12
N
SO2Me
H
H
10 (5 mol %)
Ag2CO3 (1 eq)
DMF, 140 °C, 2 h
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Scheme 2. Synthesis and Heck cyclization of gem dimethyl analogue 12. 
 
2.3 Diversity-based applications of the phenanthridine cyclization reaction 
The synthesis of natural-product-like libraries based on strategies which make use of the rapid introduction of 
stereochemical and structural diversity,
22
 is one which has gained prominence in recent years as a means to 
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efficiently cover chemical space.
23
 The initial results obtained for the cyclization of sulfonamide 5a under 
"neutral" conditions with the Hermann-Beller catalyst (Table 1, entry 10) offer considerable potential in this 
direction. In one step, the phenanthridine core unit is formed, whilst at the same time the potential for further 
diversification, through reaction of the newly-formed double bond at each of the three positions, 1,2, 2,3 and 
3,4, is introduced. In combination with different amine precursors a large and diverse compound library based 
on the phenanthridine core might be rapidly assembled (Scheme 3). 
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Scheme 3. Diversity oriented synthesis of a phenanthridine library. 
To determine the potential versatility of such an approach we screened the use of the Herrmann-Beller catalyst 
across the full range of amine precursors 5a-e (Table 3). Whilst the Boc and Cbz protected substrates (5b and 
5c) behaved in a similar manner to 5a, giving a double bond isomer profile suitable for diversity-based 
applications, the Bn and PMB protected substrates (5d and 5e) gave predominantly the 1,2 isomer. 
Amine P t Yield (%) Ratio (7:8:9) 
5a SO2Me 3h 98 44:31:25 
5b Boc 3 h 95 36:38:26 
5c Cbz 3 h 99 33:39:28 
5d Bn 5 h 93 83:8:9 
5e PMB 5 h 93 74:13:13 
a
 Reagents and Conditions: aryl halide (1 eq), MeNCy2 (4 eq), palladacycle 10 (5 mol %), DMF, 140 °C. 
Table 3. Cyclization under neutral Herrmann-Beller conditions.
a 
 
The highly reactive catalyst (
t
Bu3P)2Pd has been used to conduct intermolecular Heck coupling reactions at 
room temperature.
24
 However this catalyst system has limited precedent in intramolecular Heck cyclizations,
25
 
and only one example of its use at low temperatures (40 
o
C) has been reported,
25c
 with no examples of its 
application in a system similar to ours. We explored the use of this catalyst with amine precursors 5a-e (Table 
4). Whilst, the intermolecular reactions are typically conducted in dioxane,
24,26-28
 the use of this solvent in our 
system led to very low conversions. A simple solvent switch to MeCN gave much more promising results and 
we observed complete conversion of sulfonamide 5a to products 7a-9a at room temperature. However, the 
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Boc and Cbz protected precursors required a slightly elevated temperature (50 °C) for the cyclization reaction 
to proceed to completion. Intriguingly, the Bn and PMB-protected substrates 5d and 5e showed little or no 
reactivity at either temperature.  
These results suggest that this low-temperature cyclization offers a viable route for the synthesis of more-
sensitive members of a phenanthridine library. 
 
Amine P Method t (h) Yield (%) Ratio (7:8:9) 
5a SO2Me A 9 99 12:65:23 
  B 4 99 55:41:4 
5b Boc A 40 50 34:43:22 
  B 7 95 34:37:29 
5c Cbz A 40 64 53:34:13 
  B 7 85 36:5:59 
5d Bn A 72 no reaction -- 
  B 40 23 n.d.
b 
5e PMB A 72 no reaction -- 
  B 40 no reaction -- 
a
 Reagents and Conditions: Method A: Aryl halide (1 eq), Pd2(dba)3 (5 mol %), 
t
Bu3PHBF4 (10 mol %), 
MeNCy2 (4 eq), MeCN, rt; Method B: As Method A at 50 °C. 
b
 not determined 
Table 4. Cyclization under low temperature conditions.
a
 
 
2.4 Preliminary mechanistic investigations 
We have shown that the double bond isomer profile obtained under each of the optimized conditions shows 
dramatic variation, e.g. from 92:6:2 to 33:39:28 for cyclization of 5c. Beller has concluded that in the 
intermolecular Heck reaction of arylbromides with cyclohexene and cyclopentene, double bond migration is 
predominantly catalyzed by the base used in the reaction, and not by a HPdX complex.
29
 In this simple 
intermolecular equivalent of our study, the choice of solvent and base was shown to have an important 
influence on the extent of C-C double bond migration, whilst different catalysts showed no significant 
changes in selectivity. In sharp contrast, our study demonstrates that in the intramolecular Heck reaction 
where the two components are linked as the protected benzylamine, the palladium catalyst plays a pivotal role 
in double bond isomerism under otherwise identical conditions (entry 8 vs entry 10, Table 1). Furthermore, 
when we re-subjected the isolated 1,2 and 2,3 double bond isomers (7a and 8a respectively) to each of the 
optimized reaction conditions, which should allow a base-catalyzed double bond migration, each isomer was 
recovered unchanged even after 48 h; strongly suggesting that the double bond ratios are established at the 
time of cyclization. Indeed when the reaction of the sulfonamide precursor 5a was monitored by 
1
H NMR, the 
double bond isomer ratio was found to be consistent with the final ratio from the earliest timepoint measured, 
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and did not show a significant deviation from this ratio through the remainder of the reaction. These results 
suggest that the double bond isomer ratio obtained in these intramolecular Heck cyclization reactions is a 
product of the differing rates of decomplexation of each catalyst compared to the rate of hydropalladation/ 
dehydropalladation in each case.
30 
 
3. Conclusions 
These catalyst screening studies allow the following conclusions to be drawn: firstly, for applications of the 
Heck cyclization reaction to give phenanthridine ring systems where a single double bond isomer is required, 
the Herrmann-Beller catalyst employed under cationic conditions (Ag2CO3) provides a >85:15 ratio of 
isomers in favour of the 1,2 isomer in all cases. Excellent yields (76-99%) are obtained in short reaction times 
(<160 min). Where the double bond migration process is hindered (e.g. in the case of the gem dimethyl 
precursor 15) a 99% yield of a single reaction product is obtained under these conditions. Intriguingly, for 
sulfonamide or carbamate protected precursors, two further options of synthetic utility have been revealed. 
Rapid cyclization (<5 h) to give high yields (95-99%) of an approximately equal mixture of three double bond 
isomers may be achieved using the Herrmann-Beller catalyst under "neutral" pathway conditions. The 
potential for exploitation of this result on comparatively sensitive substrates is increased by using the highly 
reactive (
t
Bu3P)2Pd catalyst; here cyclization may be achieved at comparatively low temperatures (r.t. – 50 
°C). These results offer considerable potential for a diversity-based approach to a phenanthridine library, as in 
a single step both the phenanthridine core and the potential for further structural diversity are introduced. We 
are currently pursuing the application of this strategy to a natural product based library. 
 
4. Experimental 
4.1 General: All non-aqueous reactions were carried out under an atmosphere of nitrogen using flame- or 
oven-dried glassware. Unless otherwise noted, starting materials and reagents were obtained from commercial 
suppliers and were used without further purification. CH2Cl2, Et3N and DIPEA were distilled from calcium 
hydride. Et2O was dried and purified by passage through activated alumina columns using a solvent 
purification system from www.glasscontour.com. Anhydrous DMF and acetonitrile were used as supplied by 
BakerDRY. Anhydrous 1,4-dioxane was used as supplied by Aldrich. Purification by flash column 
chromatography was carried out using Merck Kieselgel 60 silica gel as the stationary phase. IR spectra were 
measured on a Biorad FTS-7 or Perkin-Elmer Paragon 1000 FT-IR spectrometer as thin films unless otherwise 
stated. 
1
H and 
13
C NMR spectra were measured on a Bruker AC250 or Bruker DPX360; J-values are in Hz. 
Melting points were determined on a Gallenkamp Electrothermal Melting Point apparatus and are 
uncorrected. Fast atom bombardment (FAB) mass spectra were obtained using a Kratos MS50TC mass 
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spectrometer at The University of Edinburgh. High performance liquid chromatography (HPLC) was carried 
out using a Gilson instrument fitted with a refractive index detector, using a microsorb 100-5 Si column 
(length 250 mm, id 21.4 mm, particle size 5 µm). A standard flow rate of 8.0 cm
3
 min
-1
 was used. All solvents 
used for HPLC were filtered prior to use. Double bond isomer ratios were assigned on the basis of the 
1
H 
NMR spectra which are included in the supporting information. 
 
4.2 Preparation of protected amines 5a-e 
4.2.1. N-(2-Bromo-benzyl)-cyclohex-2-enyl-amine hydrochloride 
To a solution of 2-bromobenzylamine hydrochloride (6.00 g, 27.0 mmol) in MeCN (100 mL) at 0 °C was 
added DIPEA (18.8 mL, 108 mmol) and the reaction was stirred for 5 mins. 3-Bromocyclohexene (3.10 mL, 
27.0 mmol) was added and the reaction stirred for 16 h at rt. The reaction was concentrated under reduced 
pressure and the residue taken up in CH2Cl2 (50 mL) and washed with NaCl (3 x 50 mL, sat aq.). The organics 
were combined, dried (MgSO4) and concentrated under reduced pressure. The residue was taken up in CH2Cl2 
(3 mL), HCl (30 mL, 1.0 M in Et2O, 30.0 mmol) added and the resultant suspension filtered to afford the 
amine hydrochloride as a colourless solid (7.15 g, 99 %). MP 142 °C; 
1H NMR δ (250 MHz, CD3OD) 7.79 
(1H, dd, Ј 8.0, 1.3), 7.66 (1H, dd, Ј 7.6), 7.53 (1H, td, Ј 7.6, 1.3), 7.43 (1H, td, 7.9, 1.7), 6.29-6.23 (1H, m), 
5.91-5.87 (1H, m), 4.46 (2H, s), 4.06-4.03 (1H, m), 2.28-2.18 (3H, m), 1.94-1.87 (3H, m); 
13
C NMR δ (250 
MHz, CD3OD) 135.4 (CH), 133.0 (CH), 131.6 (CH), 131.1 (CH), 130.9 (C), 128.0 (CH), 124.5 (C), 120.7 
(CH), 54.3 (CH), 46.9 (CH2), 24.8 (CH2), 23.9 (CH2), 18.8 (CH2); m/z (FAB, THIOG) 266 ([
81Br
M-H]
+
, 86 %), 
264 ([
79Br
M-H]
+
, 70), 262 (27), 239 (25), 238 (28.5), 186 (91), 184 (88) ; HRMS (FAB, THIOG) Found: 
[
81Br
M-H]
+
, 266.0372. C13H15N
81
Br requires 266.0369. Found: [
79Br
M-H]
+
, 264.0383. C13H15N
79
Br requires 
264.0388. Free Amine: Rf [3: 1 hexane: EtOAc] = 0.90; υmax (CH2Cl2)/cm
-1
 3361, 1466, 1436, 1010, 747; 
1
H 
NMR δ (250 MHz, CDCl3) 7.68 (1H, dd, Ј 7.9, 1.3), 7.60 (1H, dd, Ј 7.7, 1.7), 7.43 (1H, td, Ј 7.4, 1.1), 7.26 
(1H, td, Ј 7.6, 1.8), 5.97-5.87 (2H, m), 4.10 (1H, d, Ј 13.8), 4.03 (1H, d, Ј 13.8), 3.38 (1H, br s), 2.17-1.66 
(6H, m); 
13C NMR δ (62.9 MHz, CDCl3) 139.5 (C), 132.5 (CH), 130.0 (CH), 129.6 (CH), 128.9 (CH), 128.2 
(CH), 127.2 (CH), 123.7 (C), 52.3 (CH), 50.8 (CH2), 29.2 (CH2), 25.1 (CH2), 19.9 (CH2). 
4.2.2. N-(2-Bromo-benzyl)-N-cyclohex-2-enyl-methane-sulfonamide 5a 
To a solution of N-(2-Bromo-benzyl)-cyclohex-2-enyl-amine hydrochloride (3.90 g, 14.6 mmol) in CH2Cl2 
(50 mL) at 0 °C was added Et3N (6.20 mL, 43.8 mmol) and methanesulfonyl chloride (3.40 mL, 43.8 mmol), 
and the reaction warmed to room temperature and stirred for 16 h. The reaction was diluted with Et2O (30 
mL) and washed with H2O (2 x 30 mL), HCl (2 x 30 mL. 1 M aq.) and NaHSO3 (2 x 30 mL, sat aq.). The 
organics were dried (MgSO4), concentrated under reduced pressure and purified by flash chromatography 
(CH2Cl2 - 1 % MeOH in CH2Cl2). The resultant solid was washed with Et2O (3 x 30 mL) and dried to afford 
sulfonamide protected amine 5a as a colourless solid (4.95 g, 99 %). Rf [3: 1 hexane: EtOAc] = 0.46; MP 100 
°C; υmax (CHCl3)/cm
-1
 1332, 1145; 
1H NMR δ (250 MHz, CDCl3) 7.67 (1H, dd, Ј 7.8, 0.8), 7.49 (1H, dd, Ј 
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7.9, 1.2), 7.33 (1H, td, Ј 7.7, 1.2), 7.12 (1H, m), 5.98-5.93 (1H, m), 5.53-5.47 (1H, m), 4.66-4.57 (1H, m), 
4.47 (1H, dd, Ј 17.7), 4.33 (1H, d, Ј 17.7), 2.97 (3H, s), 1.99-1.92 (3H, m), 1.70-1.34 (3H, m); 13C NMR δ 
(62.9 MHz, CDCl3) 137.7 (C), 133.7 (CH), 132.1 (CH), 129.2 (CH), 128.4 (CH), 127.3 (CH), 126.5 (CH), 
121.9 (C), 55.6 (CH), 47.5 (CH2), 39.4 (CH3), 28.7 (CH2), 24.2 (CH2), 21.4 (CH2); m/z (FAB, THIOG) 346 
([
81Br
M+H]
+
, 64 %), 344 ([
79Br
M+H]
+
, 68), 266 (80), 264 (85); HRMS (FAB, THIOG) Found: [
81Br
M+H]
+
, 
346.0326. C14H19NO2S
81
Br requires 346.0301. Found: [
79Br
M+H]
+
 344.0346. C14H19NO2S
79
Br requires 
344.0320. 
4.2.3. (2-Bromo-benzyl)-cyclohex-2-enyl-carbamic acid tert-butyl ester 5b 
To a suspension of N-(2-Bromo-benzyl)-cyclohex-2-enyl-amine hydrochloride (500 mg, 1.87 mmol) in 
CH2Cl2 (20 ml) was added Et3N (395 µL, 2.81 mmol). After 10 mins, the reaction was cooled to 0 °C, Boc2O 
(613 mg, 2.81 mmol) in CH2Cl2 (5 mL) added and the reaction was stirred for a further 10 mins. The reaction 
was warmed to room temperature and stirred for 16 h. The reaction was diluted with CH2Cl2 (20 mL), 
extracted with NaCl (3 x 20 mL, sat aq.), dried (MgSO4) and concentrated under reduced pressure. Flash 
chromatography (hexane: EtOAc: Et3N, 10: 1: 0.1) afforded Boc protected amine 5b as a colourless oil (685 
mg, 90 %). Rf [3:1 hexane: EtOAc] = 0.8; MP 81 °C; υmax (CHCl3)/cm
-1
 3057, 3021, 1695, 1274, 1253; 
1
H 
NMR δ (360 MHz, 318 K, CDCl3) 7.51 (1H, d, Ј 7.7), 7.29-7.26 (2H, m), 7.11-7.07 (1H, m), 5.83 (1H, br s), 
5.50 (1H, d, Ј 10.1), 4.90 (1H, br s), 4.38 (2H, br s), 2.10-1.81 (3H, m), 1.81-1.70 (1H, m), 1.55-1.46 (2H, m), 
1.35 (9H, s); 
13C NMR δ (90.6 MHz, 318 K, CDCl3) 155.6 (C), 132.2 (CH), 131.7 (CH), 130.8 (C), 128.0 
(CH), 127.7 (CH), 127.3 (CH), 126.9 (CH), 121.9 (C), 79.7 (C), 53.0 (CH), 52.6 (CH2), 28.0 (3xCH3), 27.3 
(CH2), 24.4 (CH2), 21.2 (CH2); m/z (FAB, THIOG) 368 ([
81Br
M+H]
+
, 12 %), 366 ([
79Br
M+H]
+
, 15), 313 (33), 
312 (68), 311 (39), 310 (70), 266 (28), 232 (57), 230 (51); HRMS (FAB, THIOG) Found: [
81Br
M+H]
+
 
368.1046. C18H25NO2
81
Br requires 368.1050. Found: [
79Br
M+H]
+
 366.1067. C18H25NO2
79
Br requires 366.1069. 
4.2.4. (2-Bromo-benzyl)-cyclohex-2-enyl-carbamic acid benzyl ester 5c 
To a suspension of NaH (143 mg, 60% dispersion in mineral oil, 3.62 mmol) in DMF (10.0 mL) at 0 °C was 
added N-(2-Bromo-benzyl)-cyclohex-2-enyl-amine hydro-chloride (500 mg, 1.65 mmol) in DMF (10.0 mL). 
The solution was stirred for 30 mins then benzyl chloroformate (302 µL, 2.15 mmol) was added dropwise and 
the reaction was warmed to room temperature and stirred for 16 h. The reaction was diluted with Et2O (20 
mL), extracted with NaCl (3 x 20.0 mL, sat aq.), dried (MgSO4) and concentrated under reduced pressure to 
give the crude product. Flash chromatography (hexane: EtOAc: Et3N, 100: 1: 0.1 – 100: 5: 0.1) afforded Cbz 
protected amine 5c as a colourless oil (570 mg, 86 %). Rf [10: 1 hexane: EtOAc] = 0.54; MP 48 °C; υmax 
(CHCl3)/cm
-1 
3064, 3021, 1699, 1407, 1258; 
1H NMR δ (360 MHz, 323K, CDCl3) 7.52 (1H, d, Ј 5.8), 7.40 – 
7.22 (7H, m), 7.11-7.08 (1H, m), 5.87-5.85 (1H, m), 5.48 (1H, d, Ј 10.2), 5.16 (2H, br s), 4.89 (1H, br s), 4.51 
(1H, d, Ј 17.4), 4.44 (1H, d, Ј 17.4), 2.11-1.84 (3H, m), 1.80-1.70 (1H, m), 1.70-1.47 (2H, m); 13C NMR δ 
(90.6 MHz, 323K, CDCl3) 156.4 (C), 138.4 (C), 136.7 (C), 132.4 (2xCH), 128.3 (CH), 127.9 (CH), 127.7 
(3xCH), 127.6 (3xCH), 127.1 (CH), 122.1 (C), 67.3 (CH2), 53.8 (CH), 47.7 (CH2), 28.1 (CH2), 24.5 (CH2), 
21.2 (CH2); m/z (FAB, 3-NOBA) 402 ([
81Br
M+H]
+
, 35 %), 400 ([
79Br
M+H]
+
, 38), 310 (22), 308 (22), 171 (69), 
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169 (50) ; HRMS (FAB, THIOG) Found: [
81Br
M+H]
+
 402.0821. C21H23O2
81
BrN requires 402.0979. Found: 
[
79Br
M+H]
+
 400.0918. C21H23O2
79
BrN requires 400.0912. 
4.2.5. Benzyl-(2-bromo-benzyl)-cyclohex-2-enyl-amine 5d 
To a suspension of N-(2-Bromo-benzyl)-cyclohex-2-enyl-amine hydrochloride (750 mg, 2.47 mmol) in DMF 
(20 mL) at 0 °C, was added NaH (217 mg, 60% dispersion in mineral oil, 5.43 mmol) and the reaction stirred 
for 30 mins. Benzyl bromide (382 µL, 3.21 mmol) was added dropwise and the reaction warmed to room 
temperature and stirred for 16 h. Et2O (20 mL) was added and the organics washed with NaCl (3 x 30 mL, sat 
aq.), dried (MgSO4), concentrated under reduced pressure and purified by flash chromatography (hexane: 
EtOAc: NH3, 100: 1: 0.1) to afford benzyl protected amine 5d as a colourless oil (712 mg, 81 %). Rf [hexane] 
= 0.29; υmax (CHCl3)/cm
-1
 3057, 3019, 1026; 
1H NMR δ (360 MHz, CDCl3) 7.71 (1H, dd, Ј 7.7, 1.6), 7.49 
(1H, dd, Ј 8.0, 1.2), 7.40 (2H, d, Ј 7.4), 7.31-7.27 (3H, m), 7.27-7.21 (1H, m), 7.07 (1H, td, Ј 7.9, 1.8), 5.89-
5.84 (1H, m), 5.79 (1H, d, Ј 10.4), 3.81 (1H, d, Ј 15.3), 3.78 (1H, d, Ј 14.0), 3.75 (1H, d, Ј 15.3), 3.63 (1H, d, 
Ј 14.0), 3.39-3.36 (1H, m), 2.08-1.95 (3H, m), 1.85-1.76 (1H, m), 1.64-1.42 (2H, m); 13C NMR δ (90.6 MHz, 
CDCl3) 140.3 (C), 139.5 (C), 132.3 (CH), 130.4 (CH), 130.3 (CH), 130.2 (CH), 128.4 (2xCH), 128.0 (2xCH), 
127.8 (CH), 127.2 (CH), 126.6 (CH), 124.0 (C), 55.2 (CH), 54.0 (CH2), 53.1 (CH2), 25.2 (CH2), 23.5 (CH2), 
21.7 (CH2); m/z (FAB, THIOG) 356 ([
81Br
M+H]
+
, 52 %), 354 ([
79Br
M+H]
+
, 47 %), 329 (35), 327 (35), 276 
(75), 274 (53), 184 (34), 171 (69), 169 (71); HRMS (FAB, THIOG) Found: [
81Br
M+H]
+
 356.0838. 
C20H23NO2
81
Br requires 356.0838. Found: [
79Br
M+H]
+
 354.0856. C20H23NO2
79
Br requires 354.0857. 
4.2.6. (2-Bromo-benzyl)-cyclohex-2-enyl-(4-methoxy-benzyl)-amine 5e 
To a suspension of N-(2-Bromo-benzyl)-cyclohex-2-enyl-amine hydrochloride (750 mg, 2.81 mmol) in DMF 
(20 mL) at 0 °C was added NaH (246 mg, 60% dispersion in mineral oil, 6.18 mmol) and the reaction was 
stirred until homogeneous. The reaction was warmed to room temperature and stirred for 30 mins, then cooled 
to 0 °C, p-methoxybenzyl bromide (614 µL, 4.21 mmol) was added and the reaction stirred for 15 mins. The 
reaction was warmed to room temperature and stirred for 16 h. Et2O (30 mL) was added, the organics washed 
with NaCl (3 x 20 mL, sat aq.), concentrated under reduced pressure and purified by flash chromatography 
(hexane: EtOAc: NH3, 100: 1.5: 0.1) to afford PMB protected amine 5e as a colourless oil (912 mg, 84 %). Rf 
[3: 1 hexane: EtOAc] = 0.81; υmax (CHCl3)/cm
-1
 2857, 1541, 1508, 1457, 1248, 750; 
1H NMR δ (360 MHz, 
CDCl3) 7.69 (1H, d, Ј 7.8), 7.47 (1H, dd, Ј 7.8), 7.31-7.25 (3H, m), 7.04 (1H, td, Ј 7.8, 1.7), 6.83 (2H, dd, Ј 
6.7, 1.8), 5.85-5.82 (1H, m), 5.76 (1H, d, Ј 10.5), 3.76 (3H, s), 3.75 (2H, m), 3.70 (1H, d, Ј 13.8), 3.55 (1H, d, 
Ј 13.8), 3.34 (1H, br s), 2.04-1.93 (3H, m), 1.83-1.75 (1H, m), 1.58-1.48 (2H, m); 13C NMR δ (90.6 MHz, 
CDCl3) 158.3 (C), 139.6 (C), 132.2 (C), 132.1 (CH), 130.4 (CH), 130.1 (2xCH), 129.4 (2xCH), 127.7 (CH), 
127.0 (CH), 123.9 (C), 113.4 (2xCH), 55.0 (CH3), 54.9 (CH), 53.3 (CH2), 52.9 (CH2), 25.2 (CH2), 23.4 (CH2), 
21.7 (CH2) ; m/z (FAB, THIOG) 389 ([
81Br
M+H]
+
, 15 %), 387 ([
79Br
M+H]
+
, 43), 359 (53), 357 (54), 306 
(43.9), 304 (41.2), 280 (21.8), 278 (24.4), 216 (35.9), 214 (21.0); HRMS (FAB, THIOG) Found: [
81Br
M+H]
+ 
388.1068. C21H25NO
81
Br requires 388.1100. Found: [
79Br
M+H]
+
 386.1121. C21H25NO
79
Br requires 386.1120). 
Page 12 of 21 
4.3 Heck cyclization conditions employed in Tables 2-4. 
4.3.1 Conditions for Table 2 
To a degassed solution of the aryl halide (1 eq) in DMF was added palladacycle 10 (5 mol %) and Ag2CO3 (1 
eq), and the reaction was heated at 140 °C. At the conclusion of the reaction (as judged by tlc), the mixture 
was allowed to cool and then diluted with Et2O (20 mL) and washed with NaCl (3 x 20 mL, sat. aq.). The 
organics were combined, dried (MgSO4) and concentrated under reduced pressure to afford the crude product, 
which was purified by column chromatography to give the stated mixture of double bond isomers. 
4.3.2. Conditions for Table 3 
To a degassed solution of the aryl halide (1 eq) in DMF was added palladacycle 10 (5 mol %) and MeNCy2 (4 
eq), and the reaction was heated at 140 °C. At the conclusion of the reaction (as judged by tlc), the mixture 
was allowed to cool and then diluted with Et2O (20 mL) and washed with NaCl (3 x 20 mL, sat. aq.). The 
organics were combined, dried (MgSO4) and concentrated under reduced pressure to afford the crude product, 
which was purified by column chromatography to give the stated mixture of double bond isomers. 
4.3.3. Conditions for Table 4 
To a degassed solution of the aryl halide (1 eq) and MeNCy2 (4 eq) in MeCN was added Pd2(dba)3 (5 mol %) 
and 
t
Bu3PHBF4 (10 mol %), and the reaction stirred at room temperature (or 50 °C) for the indicated time. At 
the conclusion of the reaction (as judged by tlc), the mixture was diluted with Et2O (20 mL) and washed with 
NaCl (3 x 20 mL, sat. aq.). The organics were combined, dried (MgSO4) and concentrated under reduced 
pressure to afford the crude product, which was purified by column chromatography to give the stated mixture 
of double bond isomers. 
4.4 Data for phenanthridines 7-9 
4.4.1 Sulfonamide- functionalized phenanthridines 7a-9a 
(4aSR,10bSR)-5-Methanesulfonyl-3,4,4a,5,6,10b-hexa-hydro-phenanthridine 7a (1,2 isomer). Colourless 
oil. Rf [3: 1 hexane: EtOAc] = 0.38; Rt [11: 9 hexane: EtOAc] 15.9 mins; max (CHCl3)/cm
-1
 3029, 1671, 1328, 
1152; 
1
H NMR  (360 MHz, CDCl3) 7.31 (1H, d, J 7.5), 7.26 (1H, t, J 7.8), 7.19 (1H, t, J 7.3), 7.10 (1H, d, J 
7.5), 5.58 (1H, ddt, J 10.0, 4.8, 1.9), 5.86 (1H, dtd, J 10.0, 3.9, 1.7), 4.59 (1H, d, J 16.2), 4.43 (1H, d, J 16.2), 
4.19 (1H, dt, J 8.4, 5.8), 3.66 (1H, br s), 2.74 (3H, s), 2.27-2.20 (2H, m), 1.87-1.81 (2H, m); 
13
C NMR  (90.0 
MHz, CDCl3) 136.9 (C), 131.1 (C), 128.5 (CH), 127.7 (CH), 127.6 (CH), 126.7 (CH), 126.3 (CH), 125.9 
(CH), 52.1 (CH), 44.1 (CH2), 38.2 (CH3), 37.4 (CH), 25.1 (CH2), 24.0 (CH2); m/z (FAB, THIOG) 264 
([M+H]
+
, 19 %), 217 (25), 130 (79), 109 (38); HRMS (FAB, THIOG) Found: [M+H]
+ 
264.1050. C14H18NO2S 
requires 264.1058. This compound was also fully characterized by COSY, HSQC and NOESY 2D NMR 
studies. 
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(4aSR,10bSR)-5-Methanesulfonyl-1,4,4a,5,6,10b-hexa-hydro-phenanthridine 8a (2,3 isomer). Colourless 
solid. Rf [3: 1 hexane: EtOAc] = 0.32; Rt [11: 9 hexane: EtOAc]18.1 mins; MP 140 °C; 
1
H NMR  (360 MHz, 
CDCl3) 7.29-7.23 (3H, m), 7.17 (1H, dd, J 6.5, 1.8), 5.69-5.66 (1H, m), 5.42 (1H, ddt, J 10.0, 5.1, 2.3), 4.53 
(2H, s), 4.29 (1H, ddd, J 10.4, 4.0, 2.4), 3.26-3.22 (1H, m), 2.94 (3H, s), 2.92-2.85 (1H, m), 2.69-2.58 (1H, 
m), 2.28-2.23 (1H, m), 1.80-1.71 (1H, m); 
13
C NMR  (90.0 MHz, CDCl3) 135.6 (C), 128.5 (C), 127.3 (CH), 
126.5 (CH), 126.4 (CH), 125.3 (CH), 124.9 (CH), 123.8 (CH), 51.7 (CH), 45.0 (CH2), 37.7 (CH3), 35.8 (CH), 
27.9 (CH2), 26.5 (CH2). This compound was also fully characterized by COSY, HSQC and NOESY 2D NMR 
studies. 
(4aSR,10bSR)-5-Methanesulfonyl-1,2,4a,5,6,10b-hexa-hydro-phenanthridine 9a (3,4 isomer). Colourless 
oil. Rf [3:1 hexane: EtOAc] = 0.39; Rt [11: 9 hexane: EtOAc] 15.4 mins; 
1
H NMR  (360 MHz, CDCl3) 7.37 
(1H, d, J 7.8), 7.26 (1H, t, J 7.2), 7.19 (1H, t, J 7.3), 7.07 (1H, d, J 7.4), 5.83-5.80 (1H, m), 5.61 (1H, dt, J 
10.2, 1.0), 4.87-4.83 (1H, m), 4.59 (1H, d, J 16.5), 4.26 (1H, d, J 16.5), 3.39 (1H, br s), 2.83 (3H, s), 2.43-2.38 
(1H, m), 2.05-1.97 (1H, m), 1.94-1.76 (2H, m); 
13
C NMR  (90.6 MHz, CDCl3) 134.5 (C), 133.0 (CH), 132.4 
(C), 127.3 (CH), 126.9 (CH), 126.1 (2xCH), 125.8 (CH), 52.4 (CH), 43.3 (CH2), 39.8 (CH3), 34.1 (CH), 25.3 
(CH2), 20.1 (CH2). This compound was also fully characterized by COSY, HSQC and NOESY 2D NMR 
studies. 
4.4.2 Boc- functionalized phenanthridines 7b-9b 
(4aSR,10bSR)-4,4a,6,10b-Tetrahydro-3H-phenanthri-dine-5-carboxylic acid tert-butyl ester 7b (1,2 
isomer). Rf [10: 1 hexane: EtOAc] = 0.42; max (CHCl3)/cm
-1
 3026, 1693, 1258, 913, 745; 
1
H NMR  (360 
MHz, 323 K, CDCl3) 7.30 (1H, d, J 7.5), 7.25-7.17 (2H, m), 7.12 (1H, d, J 7.2), 6.17-6.13 (1H, m), 5.87-5.83 
(1H, m), 4.71 (1H, d, J 16.5), 4.41 (1H, br s), 4.39 (1H, d, J 16.5), 3.57 (1H, br s), 2.31-2.27 (1H, m), 2.15-
2.05 (1H, m), 1.79-1.69 (1H, m), 1.61-1.40 (10H, m, 3 x CH3+CHCHD); 
13
C NMR  (90.0 MHz, 323 K, 
CDCl3) 155.0 (C), 137.8 (C), 132.5 (C), 128.3 (CH), 128.1 (C), 127.6 (CH), 127.3 (CH), 126.8 (CH), 126.1 
(CH), 125.9 (CH), 79.6 (CH), 43.5 (CH2), 37.3 (CH), 28.5 (3xCH3), 25.3 (CH2), 24.2 (CH2); m/z (FAB, 
THIOG) 284 ([M-H]
+
, 44 %), 228 (66), 184 (49), 130 (25); HRMS (FAB, THIOG) Found: [M-H]
+ 
284.1643. 
C18H22NO2 requires 284.1650. 
Diagnostic data for 8b2,3 isomer). 1H NMR  (360 MHz, 323 K, CDCl3) 5.73-5.65 (1H, m), 5.44-5.40 
(1H, m), 4.55 (1H, d, J 10.9), 4.48 (1H, d, J 10.9), 3.21 (1H, t, J 4.8), 2.88 (1H, dd, J 29.3, 5.0), 2.67-2.55 
(1H, m). 
Diagnostic data for 9b3,4 isomer). 1H NMR  (360 MHz, 323 K, CDCl3); 5.73-5.65 (1H, m), 5.53 (1H, dd, 
J 10.2, 0.9), 5.09 (1H, br s), 4.86 (1H, d, J 16.8), 4.25 (1H, d, J 16.8), 3.30 (1H, br s), 2.45-2.38 (1H, m). 
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4.4.3 Cbz- functionalized phenanthridines 7c-9c 
(4aSR,10bSR)-4,4a,6,10b-Tetrahydro-3H-phenanthri-dine-5-carboxylic acid benzyl ester 7c (1,2 
isomer). Rf [10: 1 hexane: EtOAc] = 0.34; max (CHCl3)/cm
-1
 3030, 1698, 1410, 1263; 
1
H NMR  (360 MHz, 
323 K, CDCl3) 7.29-7.22 (6H, m), 7.19-7.07 (2H, m), 7.01 (1H, d, J 6.1), 6.06-6.02 (1H, m), 5.77-5.73 (1H, 
m), 5.12 (2H, s), 4.72 (1H, d, J 16.6), 4.41 (1H, br s), 4.36 (1H, d, J 16.6), 3.49 (1H, br s), 2.24-2.09 (1H, m), 
2.07-1.95 (1H, m), 1.67-1.63 (1H, m), 1.56-1.48 (1H, m); 
13
C NMR  (90.6 MHz, 323 K, CDCl3) 155.5 (C), 
137.6 (C), 136.9 (C), 132.0 (C), 128.4 (2xCH), 128.3 (CH), 127.9 (CH), 127.8 (2xCH), 127.6 (CH), 127.1 
(CH), 127.0 (CH), 126.0 (CH), 126.0 (CH), 67.1 (CH2), 50.7 (CH), 43.6 (CH2), 37.2 (CH), 25.1 (CH2), 24.2 
(CH2) ; m/z (FAB, THIOG) 320 ([M+H]
+
, 24 %), 318 ([M-H]
+
, 51), 274 (37), 228 (26), 154 (61); HRMS 
(FAB, THIOG) Found: [M-H]
+
 318.1483. C21H20NO2 requires 318.1494. 
Diagnostic data for 8c2,3 isomer). 1H NMR  (360 MHz, 323 K, CDCl3) 5.69-5.65 (1H, m), 5.41-5.37 (1H, 
m), 4.65 (1H, d, J 16.6), 4.59 (1H, d, J 16.6), 3.20 (1H, br s), 2.88-2.81 (1H, m), 2.63-2.55 (1H, m). 
Diagnostic data for 9c3,4 isomer). 1H NMR  (360 MHz, 323 K, CDCl3) 5.75-5.71 (1H, m), 5.55 (1H, d, J 
9.7), 4.95 (1H, d, J 16.6), 4.33 (1H, d, J 16.6), 3.33 (1H, br s). 
4.4.4 Bn-functionalized phenanthridines 7d-9d 
(4aSR,10bSR)-5-(Benzyl)-3,4,4a,5,6,10b-hexahydro-phenanthridine 7d (1,2 isomer). Rf [10: 1 hexane: 
EtOAc] = 0.44; max (CHCl3)/cm
-1
 3025, 1642, 1602, 1260; 
1
H NMR  (360 MHz, CDCl3) 7.35 (2H, d, J 7.0), 
7.29-7.20 (4H, m), 7.19 (1H, t, J 7.6), 7.10 (1H, t, J 7.6), 6.89 (1H, d, J 7.6), 6.06-6.02 (1H, ddt, J 9.8, 4.2, 
1.8), 5.73-5.70 (1H, ddt, J 9.8, 5.5, 2.4), 3.89 (1H, d, J 13.3), 3.75 (1H, d, J 15.6), 3.66 (1H, d, J 13.3), 3.58 
(1H, br s), 3.54 (1H, d, J 15.6), 3.14 (1H, ddd, J 10.6, 5.2, 2.5), 2.21-2.07 (2H, m), 1.86-1.77 (1H, m), 1.69-
1.61 (1H, m); 
13
C NMR  (90.0 MHz, CDCl3) 139.0 (C), 137.7 (C), 133.4 (C), 128.8 (CH), 128.7 (2xCH), 
128.2 (2xCH), 127.7 (CH), 127.4 (CH), 126.9 (CH), 126.4 (2xCH), 125.2 (CH), 58.4 (CH2), 56.1 (CH), 50.9 
(CH2), 37.8 (CH), 24.3 (CH2), 19.4 (CH2); m/z (FAB, THIOG) 276 ([M+H]
+
, 76 %), 200 (35), 184 (55), 154 
(93), 136 (83); HRMS (FAB, THIOG) Found: [M+H]
+ 
276.1755. C20H22N requires 276.1754. This compound 
was also fully characterized by COSY, HSQC and NOESY 2D NMR studies. 
Diagnostic data for 8d2,3 isomer). 1H NMR  (360 MHz, CDCl3) 5.70-5.67 (1H, m), 5.58-5.55 (1H, m), 
2.74-2.65 (1H, m).  
Diagnostic data for 9d3,4 isomer). 1H NMR  (360 MHz, CDCl3) 5.96-5.92 (1H, m), 5.89-5.86 (1H, m). 
4.4.5 PMB- functionalized phenanthridines 7e-9e 
(4aSR,10bSR)-5-(4-Methoxy-benzyl)-3,4,4a,5,6,10b-hexahydro-phenanthridine 7e (1,2 isomer). Rf [10: 1 
hexane: EtOAc] = 0.23; max (CHCl3)/cm
-1
 3024, 1647, 1609, 1511; 
1
H NMR  (360 MHz, CDCl3) 7.33-7.29 
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(3H, m), 7.18 (1H, t, J 7.3), 7.10 (1H, t, J 7.6), 6.96 (1H, d, J 7.6), 6.90-6.88 (2H, m), 6.12-6.08 (1H, m), 5.79-
5.76 (1H, m), 3.89 (1H, d, J 13.0), 3.82 (3H, s), 3.80 (1H, d, J 16.1), 3.67 (1H, d, J 13.0), 3.62 (1H, br s), 3.59 
(1H, d, J 16.1), 3.12 (1H, ddd, J 10.6, 5.4, 2.6), 2.20-2.00 (2H, m), 1.90-1.63 (2H, m); 
13
C NMR  (90.0 MHz, 
CDCl3) 158.6 (C), 137.7 (C), 133.4 (C), 130.9 (C), 129.9 (2xCH), 128.8 (CH), 127.6 (CH), 127.4 (CH), 126.4 
(CH), 126.3 (CH), 125.2 (CH), 113.6 (2xCH), 57.7 (CH2), 55.9 (CH), 55.1 (CH3), 50.8 (CH2), 37.8 (CH), 24.4 
(CH2), 19.2 (CH2); m/z (FAB, THIOG) 306 ([M+H]
+
, 56 %), 305 ([M]
+
, 58), 304 ([M-H]
+
, 69), 251 (12.4), 
184 (46.1); HRMS (FAB, 3-NOBA) Found: [M]
+ 
305.1779. C21H23NO requires 305.1780. This compound 
was also fully characterized by COSY, HSQC and NOESY 2D NMR studies. 
Diagnostic data for 8e2,3 isomer). 1H NMR  (360 MHz, CDCl3) 5.68-5.65 (1H, m), 5.56-5.53 (1H, m), 
3.98 (1H, d, J 13.2), 3.18 (1H, br s), 2.71-2.65 (1H, m). 
Diagnostic data for 9e3,4 isomer). 1H NMR  (360 MHz, CDCl3) 5.96-5.91 (1H, m), 5.90-5.84 (1H, m), 
4.05 (1H, J 13.3), 3.11 (1H, br s). 
4.5 Synthesis and cyclization of gem dimethyl analogue 12 
4.5.1 5,5-Dimethyl-cyclohex-2-enol20 
To a solution of enone 13
19
 (661 mg, 5.32 mmol) in Et2O (12 mL) at 0 °C was added portionwise LiAlH4 (201 
mg, 5.32 mmol). The reaction was stirred for at 0 °C for 40 mins then quenched by the addition of 
Na2SO4.5H2O portionwise. The reaction was filtered and the filtrate vigorously stirred with potassium sodium 
tartate (50 mL, sat. aq.) for 1 h. The organic phase was separated and the aqueous phase washed with Et2O (3 
x 40 mL). The combined organics were dried (MgSO4) and concentrated under reduced pressure to afford 5,5-
dimethyl-cyclohex-2-enol as a colourless oil (525 mg, 72 %). Rf [3: 1 hexane: EtOAc] = 0.37; υmax 
(CHCl3)/cm
-1
 3336, 2952, 1650, 1454, 1089, 1037, 725; 
1H NMR δ (250 MHz, CDCl3) 5.71 (2H, s), 4.29-4.22 
(1H, m), 1.88-1.57 (3H, m), 1.31 (1H, dd, Ј 12.3, 8.7), 1.00 (3H, s), 0.92 (3H, s);13C NMR δ (62.9 MHz, 
CDCl3) 129.1 (CH), 128.0 (CH), 66.2 (CH), 45.3 (CH2), 38.9 (CH2), 31.2 (CH3), 30.7 (C), 26.0 (CH3); m/z 
(FAB, THIOG) 149 ([M+Na]
+
, 33 %), 127 ([M+H]
+
, 5), 125 ([M-H]
+
, 12), 124 (18), 111 (53); HRMS (FAB, 
THIOG) Found: [M-H]
+ 
125.0968. C8H13O requires 125.0966. 
4.5.2 3-Bromo-5,5-dimethyl-cyclohex-2-ene 14 
To a stirred solution of 5,5-dimethyl-cyclohex-2-enol (2.00 g, 15.8 mmol) and CBr4 (11.1 g, 33.3 mmol) in 
Et2O (75 mL) at 0 °C was added PPh3 (8.00 g, 33.3 mmol). The reaction was warmed to room temperature 
and stirred for 2 h. The reaction was filtered and the filtrate concentrated under reduced pressure to afford a 
colourless solid and yellow oil. These were washed with pentane (2 x 100 mL) and the combined washings 
dried (MgSO4) and concentrated under reduced pressure to afford bromide 14 as a pale yellow oil (2.00 g, 67 
%). This material was found to be unstable to flash chromatography and thus was used without further 
purification. Rf [3: 1 hexane: EtOAc] = 0.46; υmax (CHCl3)/cm
-1 
1437, 1120, 723, 694; 
1H NMR δ (250 MHz, 
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CDCl3) 5.90-5.84 (1H, m), 5.75-5.71 (1H, m), 4.79-4.77 (1H, m), 2.14-1.88 (3H, m), 1.80-1.70 (1H, m), 1.02 
(3H, s), 0.96 (3H, s);
13C NMR δ (62.9 MHz, CDCl3) 129.0 (CH), 128.2 (CH), 47.5 (CH), 46.7 (CH2), 38.1 
(CH2), 31.9 (C), 30.7 (CH3), 25.4 (CH3). 
4.5.3 N-(2-Bromo-benzyl)-5,5-dimethylcyclohex-2-enyl-amine 
To a suspension of 2-bromobenzylamine hydrochloride (412 mg, 1.85 mmol) in MeCN (20 mL) was added 
DIPEA (1.30 mL, 7.40 mmol) and the reaction stirred for 10 mins. Bromide 14 (700 µL, 3.70 mmol) was 
added dropwise and the reaction stirred at room temperature for 16 h. The reaction was concentrated under 
reduced pressure and the residue taken up in CH2Cl2 (20 mL) and washed with NaCl (3 x 20 mL, sat. aq.). The 
combined organics were dried (MgSO4) and concentrated under reduced pressure to afford N-(2-bromo-
benzyl)-5,5-dimethylcyclohex-2-enyl-amine as a brown oil (340 mg, 63 %). Rf [3: 1 hexane: EtOAc] = 0.37; 
υmax (CHCl3)/cm
-1
 3307, 1776, 1651, 1466, 1025, 750; 
1H NMR δ (360 MHz, CDCl3) 7.53 (1H, dd, Ј 7.9, 1.2), 
7.46 (1H, dd, Ј 6.1, 1.6), 7.28 (1H, t, Ј 7.4, 6.1), 7.11 (1H, td, Ј 7.8, 1.6), 5.76-5.70 (2H, m), 3.92 (2H, s), 
3.31-3.24 (1H, m), 1.92 (1H, dd, Ј 17.8, 3.4), 1.79-1.71 (2H, m), 1.23 (1H, t, Ј 10.6), 1.00 (3H, s), 0.92 (3H, 
s); 
13C NMR δ (90.6 MHz, CDCl3) 139.6 (C), 132.5 (CH), 130.0 (CH), 128.4 (CH), 128.3 (CH), 127.3 (CH), 
127.2 (CH), 123.7 (C), 52.0 (CH), 50.7 (CH2), 43.2 (CH2), 39.0 (CH2), 31.8 (CH3), 30.2 (C), 25.4 (CH3); m/z 
(FAB, THIOG) 296 ([
81Br
M+H]
+
, 96 %), 294 ([
79Br
M+H]
+
, 100), 239 (25), 188 (33), 186 (51), 171 (42), 169 
(48) ; HRMS (FAB, THIOG) Found: [
81Br
M+H]
+ 
296.0845. C15H21N
81
Br requires 296.0837. Found: 
[
79Br
M+H]
+
, 294.0848. C15H21N
79
Br requires 294.0857. 
4.5.4 N-(2-Bromo-benzyl)-N-5,5-dimethylcyclohex-2-enyl-methanesulfonamide 12 
To N-(2-bromo-benzyl)-5,5-dimethylcyclohex-2-enyl-amine (180 µL, 0.62mmol) in CH2Cl2 (5 mL) at 0 °C 
was added Et3N (262 µL, 1.87 mmol) and methanesulfonyl chloride (214 µL, 1.87 mmol). The reaction was 
warmed to room temperature and stirred for 3 h. The reaction was extracted with HCl (2 x 10 mL, 1 M aq.) 
then NaOH (2 x 10 mL, 1 M aq.) and the combined organics dried (MgSO4), concentrated under reduced 
pressure and purified by flash chromatography (hexane: EtOAc, 10: 1 – 5: 1) to afford sulfonamide 12 as a 
colourless oil (150 mg, 65 %). Rf [3: 1 hexane: EtOAc] = 0.77; υmax (CHCl3)/cm
-1
 1335, 1159, 913, 745; 
1
H 
NMR δ (360 MHz, CDCl3) 7.66 (1H, d, Ј 7.0), 7.50 (1H, dd, Ј 8.0, 1.2), 7.32 (1H, td, Ј 7.6, 0.7), 7.11 (1H, Ј 
7.6, 1.8), 5.89-5.83 (1H, dddd, Ј 10.3, 5.2, 2.7, 2.5), 5.49 (1H, dd, Ј 10.3, 1.3), 4.63-4.47 (1H, m), 4.45 (1H, d, 
Ј 17.6), 4.31 (1H, d, Ј 17.6), 2.98 (3H, s), 1.92-1.83 (1H, m), 1.75-1.68 (1H, m), 1.68-1.60 (1H, m), 1.30-1.25 
(1H, m), 0.95 (3H, s), 0.91 (3H, s) ; 
13C NMR δ (90.6 MHz, CDCl3) 137.7 (C), 132.1 (2xCH), 129.3 (CH), 
128.5 (CH), 127.4 (CH), 125.1 (CH), 122.0 (C), 54.9 (CH), 47.7 (CH2), 40.8 (CH2), 39.5 (CH3), 38.2 (CH2), 
31.7 (CH3), 31.0 (C), 24.8 (CH3); m/z (FAB, THIOG) 374 ([
81Br
M+H]
+
, 80 %), 372 ([
79Br
M+H]
+
, 93), 294 (49), 
292 (53), 264 (23), 262 (12), 171 (100), 169 (100); HRMS (FAB, THIOG) Found: [
81Br
M+H]
+
,
 
374.0612. 
C16H23O2NS
81
Br requires 374.0612. Found: [
79Br
M+H]
+
, 372.0628. C16H23O2NS
79
Br requires 372.0633. 
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4.5.5 (4aSR,10bSR)-3,3-Dimethyl-5-Methanesulfonyl-4,4a,5,6,10b-tetrahydro-phenanthridine 11.  
The general procedure for Table 2 was employed using sulfonamide 12 (40 mg, 0.11 mmol), palladacycle 10 
(5.0 mg, 5.4 mol) and Ag2CO3 (30 mg, 0.11 mmol) in DMF (3 mL). After 2 h at 140 °C, work up and 
column chromatography (10:1 – 5:1, hexane:EtOAc) afforded phenanthridine 11 as a colourless solid (31 mg, 
99 %). Rf [3: 1 hexane: EtOAc] = 0.48; MP 104 °C; max (CHCl3)/cm
-1
 2957, 1332, 1153; 
1
H NMR  (360 
MHz, CDCl3) 7.32 (1H, d, J 7.5), 7.24 (1H, t, J 7.3), 7.20 (1H, t, J 7.9), 7.10 (1H, d, J 7.3), 6.03 (1H, dd, J 
10.0, 5.6), 5.59 (1H, d, J 10.0), 4.60 (1H, d, J 16.2), 4.43 (1H, d, J 16.2), 4.41 (1H, dd, J 15.5, 6.2), 3.59 (1H, 
t, J 5.6), 2.87 (3H, s), 1.64-1.60 (2H, m), 1.15 (3H, s), 0.94 (3H, s); 
13
C NMR  (90.6 MHz, CDCl3) 138.7 
(CH), 136.3 (C), 130.3 (C), 127.9 (CH,), 127.3 (CH), 126.1 (CH), 126.0 (CH), 123.7 (CH), 49.8 (CH), 43.3 
(CH2), 39.0 (CH3), 38.2 (CH2), 36.6 (CH), 34.0 (C), 30.3 (CH3), 28.3 (CH3); m/z (FAB, THIOG) 292 
([M+H]
+
, 100 %), 291 ([M]
+
, 82), 213 (44), 197 (40), 165 (12), 130 (15), 94 (89); HRMS (FAB, THIOG) 
Found: [M+H]
+ 
292.1371. C16H22NO2S requires 292.1371. 
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